Two Sigma Investments
TMCI icon

Two Sigma Investments’s Treace Medical Concepts TMCI Stock Holding History

Two Sigma Investments’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,081
Closed -$230K – 3931
2025
Q2 		$230K Sell
39,081
-42,222
-52% -$275K ﹤0.01% 2874
2025
Q1 		$682K Sell
81,303
-72,521
-47% -$652K ﹤0.01% 2377
2024
Q4 		$1.14M Sell
153,824
-7,346
-5% -$49.1K ﹤0.01% 2091
2024
Q3 		$935K Buy
161,170
+35,207
+28% +$226K ﹤0.01% 2161
2024
Q2 		$838K Buy
125,963
+58,551
+87% +$473K ﹤0.01% 2083
2024
Q1 		$880K Buy
+67,412
New +$899K ﹤0.01% 2029
2023
Q4 		– Sell
-39,774
Closed -$521K – 3384
2023
Q3 		$521K Sell
39,774
-70,531
-64% -$1.29M ﹤0.01% 2255
2023
Q2 		$2.82M Buy
110,305
+763
+0.7% +$19.7K 0.01% 1227
2023
Q1 		$2.76M Buy
109,542
+94,391
+623% +$2.22M 0.01% 1191
2022
Q4 		$348K Buy
+15,151
New +$349K ﹤0.01% 2184

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments's TMCI Position: Q3 2025 in Review

Two Sigma Investments sold out of Treace Medical Concepts (TMCI) in Q3 2025, closing a stake of 39,081 shares — an estimated $230K sold.

Two Sigma Investments first reported a position in TMCI in Q4 2022 and held it in 10 quarters. The position peaked at $2.82M in Q2 2023. 119 funds tracked by Wall St. Rank hold TMCI as of Q3 2025.

  • Two Sigma Investments reported no remaining Treace Medical Concepts position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Investments sold 39,081 Treace Medical Concepts shares in Q3 2025, an estimated $230K.
  • Two Sigma Investments first reported a position in Treace Medical Concepts in Q4 2022 and held it in 10 quarters.
  • Two Sigma Investments's Treace Medical Concepts position peaked at $2.82M in Q2 2023.
  • 119 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.